SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?


To: TokyoMex who wrote (19698)5/20/1998 1:59:00 PM
From: Brent  Read Replies (1) | Respond to of 34592
 
FONR: Will get monetary compensation from Toshiba: news:

Note:
- FONR has some cross licensing with Toshiba already, so they are kind of partners, so the PR is toned down because of that IMO
- It seems the news is not on all the wires yet
- this is an OFF-COURT settlement, amount not disclosed, but PR just told me they expect payments within weeks
- FONR has already won a similar suit against GE last October

FONAR ANNOUNCES PATENT INFRINGEMENT SETTLEMENT;
FONAR WILL RECEIVE A MONETARY PAYMENT FROM TOSHIBA

MELVILLE, NEW YORK, May 20, 1998 FONAR Corporation (NASDAQ-FONR), and Toshiba Corporation are pleased to announce that they have amicably resolved their pending patent infringement litigation in the United States District Courts in New York and California in which each company had asserted certain of its patents relating to magnetic resonance imaging technology were infringed by the other. Neither party admits liability in the Settlement Agreement. The parties have cross-licensed each other on the patents-in-suit and FONAR will receive a monetary payment from Toshiba. Other terms of the settlement are confidential.

FONAR continues to assert and protect its intellectual property rights. The Company has also reached settlement agreements with Hitachi, Philips, and Siemens for its MRI patents.

Most significantly, on October 6, 1997, the U.S. Supreme Court denied GE?s certiorari petition which ended that patent infringement suit. Previously, GE had paid FONAR a total of $128.7 million.

FONAR has been highly successful with two of its patents. One is ?The Cancer Detection Patent? which is the world?s first MRI patent. The other is the Multi-Angle Oblique Patent. Both of these were successful against GE. FONAR?s patent portfolio includes the MRI magnet patents that originated ?OPEN MRI.?

FONAR is represented by Ronald J. Schutz and Martin R. Lueck of the Minneapolis Law Firm of Robins, Kaplan, Miller and Ciresi.
____________________________________________________
Be sure to visit FONAR?s Web site for Company product
and investor information.
www.fonar.com

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company?s financial results may be found in the company?s filings with the Securities and Exchange Commission.
###



To: TokyoMex who wrote (19698)5/20/1998 2:03:00 PM
From: Brent  Respond to of 34592
 
FONR: Background info:

Magnetic resonance imaging pioneer FONAR brought its
first MRI scanner to market in 1980, and today it makes, sells, and
services its QUAD series, featuring "open" MRIs with high field
strength. The series, with unit prices of $700,000 to $900,000, is
marketed by distributors and at trade shows. FONAR's foreign
markets include Korea, Mexico, and Poland. Subsidiary U.S. Health
Management provides management and administrative services, office
space, equipment, repair and maintenance of equipment, and
personnel to physicians and diagnostic centers. FONAR manages 21
medical sites, mostly in New York and Florida; this business
segment accounts for nearly half of the firm's revenues.

%% Products & buz:
- QUAD 7000's (open scanner)
- QUAD 12000 (only high-field Open MRI on the market as of Nov 97)
- OR-360 or MRI operating Room is being developed (announced nov 97)
- does not seem to be anything else ?
- U.S. Health Management Corporation (HMC), a physician practice management company
HMC will provide
management services, administrative services, office space, equipment,
repair and maintenance service and clerical and other non-medical personnel
to physicians and other medical providers, including diagnostic imaging
(10K)

60m shares
New strategy based on licensing their technology (they are the pioneer in the MRI buz) + Management service (which has a great potential IMO)

Announced their Q this morning also: Sales +56%, -6c/share EPS, improving margin:

FONAR CORPORATION
110 Marcus Dr. Melville, New York 11742-4292
Phone: 516/694-2929; Fax: 516/249-3734
FOR RELEASE: Immediately
CONTACT: David Terry
PHONE: (919) 847-9535
FAX: (919) 676-8629
E-MAIL investor@fonar.com; FonarDT@aol.com


FONAR REPORTS 59% INCREASE IN REVENUE;
NEW SUBSIDIARY CONTINUES GROWTH

MELVILLE, NEW YORK, May 19, 1998 FONAR Corporation (NASDAQ:FONR) reported revenues for the
nine months ending March 31, 1998 of $20.7 million,
up 59% from the $13.0 million reported for the nine
months ended March 31, 1997. The Company reported a
net loss of approximately $8.0 million and an
operating loss of $10.9 million for the nine months
ending March 31, 1998, reflecting a 22% improvement
over the operating loss of $14.0 million for the
nine months ending March 31, 1997.

FONAR?s new physician practice management (PPM)
subsidiary, U.S. Health Management Corporation
(HMC), sustained its dynamic growth in more than
doubling its revenues over the prior year. In
addition, the PPM?s operating income for the nine
months ending March 31, 1997, was $3.0 million on
$14.9 million in revenues (before merger-related
expenses and amortization of goodwill) compared to
an operating income of $1.1 million on $7.2 million
in revenues for the nine months ending March 31,
1997.

Tim Damadian, President and CEO of HMC, stated, ?I
am very pleased with our 100% increase in revenue,
as well as nearly doubling our operating income. We
continue to exceed the goals of our business plan.?

Dr. Damadian, President and Chairman of FONAR
stated, ?An examination of this quarterly report
indicates a positive trend in both earnings and
especially revenues. The Company?s commitment to
R&D remains priority one. The improved revenues
underscore the clear benefit being derived from the
synergy of FONAR and HMC.?

CONDENSED STATEMENT OF OPERATIONS

Three Months
Ending March 31, 1998 1997
Revenues $7,136,000 $4,442,000 (1)(2)
Net Income (Loss) $(3,669,000) $(5,565,000)
Net Income
Per Share (Loss) $(0.06) $(0.09)

Nine Months
Ending March 31, 1998 1997
Revenues $20,700,000 $13,048,000 (1)(2)
Net Income (Loss) $(7,990,000) $(4,138,000)
Net Income
Per Share (Loss) $(0.13) $(0.07)

(1)Statement of Operations for March 31, 1997. This
includes results of operations for Raymond V.
Damadian, M.D. MR Scanning Centers Management
Company and two related Florida companies (RVDC)
subsequently acquired by FONAR as of June 30, 1997
and are restated for prior fiscal periods for the
purpose of comparative financial statement
presentation.

(2) The numbers included in the March 31, 1997
original 10-Q have been adjusted to give effect to
the acquisition on RVDC.
#

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company?s financial results may be found in the company?s filings with the Securities and Exchange Commission.
###